Nath Bio-Genes (India) liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

2.21×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.97×	1.97×	1.89×	2.18×	2.41×
0.83×	0.83×	0.96×	1.30×	1.45×
76.0	76.0	88.9	77.4	38.0
384	384	325	309	304

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATHBIOGEN₹132.38

Nath Bio-Genes (India) Limited

· FMCG & Retail

₹ CrorePeersSARVESHWAR INDOUS SUKHJITS KOHINOOR AGRITECH REGAAL BSHSL GULPOLYMcap ₹252 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	2.21
Current Ratio	2.41	2.18	1.89	1.97	1.97
Quick Ratio	1.45	1.30	0.96	0.83	0.83
Cash, Equiv & ST Investments	38.0	77.4	88.9	76.0	76.0
Working Capital	304.4	309.2	324.7	384.2	384.2

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.